Tessella has begun digging deeply into adaptive trials, through simulating designs including use of predictive or prognostic biomarkers (see, ???Boosting Adaptive Clinical Trials,??? Bio???IT World, Jul 2009). ???It???s not only that we can deal with recycling information from early recruits to help allocate patients to trial arms but also we can offer to make the best of information which comes i